Evidence map›Paper›PMID 36980535›Full record

ArticleCancers2023

Eman Abdelghani, Kathleen M Schieffer, Catherine E Cottrell, Anthony Audino, Kristin Zajo, Nilay Shah

Open access · goldFull text read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Onco-Breastomics: An Eco-Evo-Devo Holistic Approach.International journal of molecular sciences · 2024
    Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Eman AbdelghaniDivision of Hematology/Oncology/Blood and Marrow Transplantation, Nationwide Children's Hospital, Columbus, OH 43205, USA.
Kathleen M SchiefferThe Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH 43215, USA.
Catherine E CottrellThe Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH 43215, USA.
Anthony AudinoDivision of Hematology/Oncology/Blood and Marrow Transplantation, Nationwide Children's Hospital, Columbus, OH 43205, USA.ORCID 0000-0002-2597-1212
Kristin ZajoDivision of Hematology/Oncology/Blood and Marrow Transplantation, Nationwide Children's Hospital, Columbus, OH 43205, USA.
Nilay ShahDivision of Hematology/Oncology/Blood and Marrow Transplantation, Nationwide Children's Hospital, Columbus, OH 43205, USA.ORCID 0000-0003-3766-3572
Nationwide Children's Hospital · US

Funding

Nationwide Foundation Pediatric Innovation Fund n/a
6 · The paper itself

Abstract

backgroundApproximately 10% of pediatric malignancies are secondary to germline alterations in cancer-predisposing genes. Checkpoint kinase 2 (

methodsPediatric oncology patients with

resultsWe identified 6 patients with germline

conclusions

Indexed as

cancercancer predispositionCHEK2genetic counselingpediatric oncology

Identifiers

PMID36980535
PMCPMC10046043
OpenAlexW4323566226

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read15
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.